Inhibitor Therapeutics, Inc.
INTI
$0.09
$0.0117.03%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -86.20% | -70.13% | -57.63% | -53.33% | -47.34% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.83% | -14.23% | -18.56% | 19.56% | 23.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -84.68% | -68.88% | -57.03% | -52.50% | -46.61% |
|
|
|||||
| Total Current Assets | -84.68% | -68.88% | -57.03% | -52.50% | -46.61% |
| Net Property, Plant & Equipment | -35.14% | -31.91% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -83.69% | -68.18% | -55.90% | -51.40% | -45.53% |
|
|
|||||
| Total Accounts Payable | 30.98% | 771.39% | 223.90% | 1,052.94% | 464.89% |
| Total Accrued Expenses | 24.68% | 4.69% | -0.52% | -5.83% | -53.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.15% | 11.54% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 24.93% | 303.70% | 7.99% | 96.19% | 294.37% |
|
|
|||||
| Total Current Liabilities | 24.93% | 303.70% | 7.99% | 96.19% | 294.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -58.54% | -49.66% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 0.14% | 8.20% | 2.52% | 2.86% | 5.16% |
|
|
|||||
| Common Stock & APIC | 0.06% | 0.04% | 0.04% | 0.04% | 0.04% |
| Retained Earnings | -6.19% | -6.36% | -6.33% | -6.76% | -6.90% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -457.64% | -246.30% | -165.08% | -99.90% | -82.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -457.64% | -246.30% | -165.08% | -99.90% | -82.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -457.64% | -246.30% | -165.08% | -99.90% | -82.71% |
|
|
|||||